89 related articles for article (PubMed ID: 33651140)
21. Upregulation of microRNA-351 exerts protective effects during sepsis by ameliorating skeletal muscle wasting through the Tead-4-mediated blockade of the Hippo signaling pathway.
Zhang LN; Tian H; Zhou XL; Tian SC; Zhang XH; Wu TJ
FASEB J; 2018 Jul; ():fj201800151RR. PubMed ID: 30040486
[TBL] [Abstract][Full Text] [Related]
22. Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers.
Chapeau EA; Sansregret L; Galli GG; Chène P; Wartmann M; Mourikis TP; Jaaks P; Baltschukat S; Barbosa IAM; Bauer D; Brachmann SM; Delaunay C; Estadieu C; Faris JE; Furet P; Harlfinger S; Hueber A; Jiménez Núñez E; Kodack DP; Mandon E; Martin T; Mesrouze Y; Romanet V; Scheufler C; Sellner H; Stamm C; Sterker D; Tordella L; Hofmann F; Soldermann N; Schmelzle T
Nat Cancer; 2024 Apr; ():. PubMed ID: 38565920
[TBL] [Abstract][Full Text] [Related]
23. Comparative analysis of YAP/TEAD inhibitors in 2D and 3D cultures of primary human hepatocytes reveals a novel non-canonical mechanism of CYP induction.
Oliva-Vilarnau N; Vorrink SU; Büttner FA; Heinrich T; Sensbach J; Koscielski I; Wienke D; Petersson C; Perrin D; Lauschke VM
Biochem Pharmacol; 2023 Sep; 215():115755. PubMed ID: 37607620
[TBL] [Abstract][Full Text] [Related]
24. Hot Spot Analysis of YAP-TEAD Protein-Protein Interaction Using the Fragment Molecular Orbital Method and Its Application for Inhibitor Discovery.
Kim J; Lim H; Moon S; Cho SY; Kim M; Park JH; Park HW; No KT
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439400
[TBL] [Abstract][Full Text] [Related]
25. Development of LM-41 and AF-2112, two flufenamic acid-derived TEAD inhibitors obtained through the replacement of the trifluoromethyl group by aryl rings.
Fnaiche A; Mélin L; Suárez NG; Paquin A; Vu V; Li F; Allali-Hassani A; Bolotokova A; Allemand F; Gelin M; Cotelle P; Woo S; LaPlante SR; Barsyte-Lovejoy D; Santhakumar V; Vedadi M; Guichou JF; Annabi B; Gagnon A
Bioorg Med Chem Lett; 2023 Oct; 95():129488. PubMed ID: 37770003
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers.
Jessen M; Gertzmann D; Liss F; Zenk F; Bähner L; Schöffler V; Schulte C; Maric HM; Ade CP; von Eyss B; Gaubatz S
Oncogene; 2024 Feb; 43(8):578-593. PubMed ID: 38182898
[TBL] [Abstract][Full Text] [Related]
27. Direct inhibition of the YAP:TEAD interaction: an unprecedented drug discovery challenge.
Chene P
ChemMedChem; 2024 Jun; ():e202400361. PubMed ID: 38863297
[TBL] [Abstract][Full Text] [Related]
28. β-elemene promotes the senescence of glioma cells through regulating YAP-CDK6 signaling.
Yang D; Xu X; Wang X; Feng W; Shen X; Zhang J; Liu H; Xie C; Wu Q; Miao X; Guo Y; Cai H; Wu L; Zhou S; Yao X; Wang Y; Xie T; Huang Z
Am J Cancer Res; 2021; 11(2):370-388. PubMed ID: 33575077
[TBL] [Abstract][Full Text] [Related]
29.
Byerly CD; Patterson LL; Pittner NA; Solomon RN; Patel JG; Rogan MR; McBride JW
bioRxiv; 2023 Mar; ():. PubMed ID: 36945589
[No Abstract] [Full Text] [Related]
30. YAP condensates are highly organized hubs.
Hao S; Lee YJ; Benhamou Goldfajn N; Flores E; Liang J; Fuehrer H; Demmerle J; Lippincott-Schwartz J; Liu Z; Sukenik S; Cai D
iScience; 2024 Jun; 27(6):109927. PubMed ID: 38784009
[TBL] [Abstract][Full Text] [Related]
31. A covalent inhibitor of the YAP-TEAD transcriptional complex identified by high-throughput screening.
Nutsch K; Song L; Chen E; Hull M; Chatterjee AK; Chen JJ; Bollong MJ
RSC Chem Biol; 2023 Nov; 4(11):894-905. PubMed ID: 37920398
[TBL] [Abstract][Full Text] [Related]
32. Releasing YAP dysfunction-caused replicative toxicity rejuvenates mesenchymal stem cells.
Yu F; Yao L; Li F; Wang C; Ye L
Aging Cell; 2023 Sep; 22(9):e13913. PubMed ID: 37340571
[TBL] [Abstract][Full Text] [Related]
33. Verteporfin selectively kills hypoxic glioma cells through iron-binding and increased production of reactive oxygen species.
Eales KL; Wilkinson EA; Cruickshank G; Tucker JHR; Tennant DA
Sci Rep; 2018 Sep; 8(1):14358. PubMed ID: 30254296
[TBL] [Abstract][Full Text] [Related]
34. YAP/TEAD-induced PRIM1 contributes to the progression and poor prognosis of gastric carcinoma.
Guo Z; Guo L
Transl Oncol; 2023 Dec; 38():101791. PubMed ID: 37741096
[TBL] [Abstract][Full Text] [Related]
35. Comparative Assessment and High-Throughput Drug-Combination Profiling of TEAD-Palmitoylation Inhibitors in Hippo Pathway Deficient Mesothelioma.
Evsen L; Morris PJ; Thomas CJ; Ceribelli M
Pharmaceuticals (Basel); 2023 Nov; 16(12):. PubMed ID: 38139762
[TBL] [Abstract][Full Text] [Related]
36. Development of HC-258, a Covalent Acrylamide TEAD Inhibitor That Reduces Gene Expression and Cell Migration.
Fnaiche A; Chan HC; Paquin A; González Suárez N; Vu V; Li F; Allali-Hassani A; Cao MA; Szewczyk MM; Bolotokova A; Allemand F; Gelin M; Barsyte-Lovejoy D; Santhakumar V; Vedadi M; Guichou JF; Annabi B; Gagnon A
ACS Med Chem Lett; 2023 Dec; 14(12):1746-1753. PubMed ID: 38116405
[TBL] [Abstract][Full Text] [Related]
37. TEAD-YAP Interaction Inhibitors and MDM2 Binders from DNA-Encoded Indole-Focused Ugi Peptidomimetics.
Kunig VBK; Potowski M; Akbarzadeh M; Klika Škopić M; Dos Santos Smith D; Arendt L; Dormuth I; Adihou H; Andlovic B; Karatas H; Shaabani S; Zarganes-Tzitzikas T; Neochoritis CG; Zhang R; Groves M; Guéret SM; Ottmann C; Rahnenführer J; Fried R; Dömling A; Brunschweiger A
Angew Chem Int Ed Engl; 2020 Nov; 59(46):20338-20342. PubMed ID: 32537835
[TBL] [Abstract][Full Text] [Related]
38. Docking analysis of verteporfin with YAP WW domain.
Kandoussi I; Lakhlili W; Taoufik J; Ibrahimi A
Bioinformation; 2017; 13(7):237-240. PubMed ID: 28943729
[TBL] [Abstract][Full Text] [Related]
39. Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer.
Zhang F; Sahu V; Peng K; Wang Y; Li T; Bala P; Aitymbayev D; Sahgal P; Schaefer A; Der CJ; Ryeom S; Yoon S; Sethi N; Bass AJ; Zhang H
Gut; 2024 Apr; ():. PubMed ID: 38621923
[TBL] [Abstract][Full Text] [Related]
40. Tumor-Derived Membrane Vesicles Restrain Migration in Gliomas By Altering Collective Polarization.
Jhunjhunwala M; Yu LS; Kuo PC; Li CY; Chen CS
ACS Appl Bio Mater; 2023 Nov; 6(11):4764-4774. PubMed ID: 37862244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
